Free Trial
→ What President Trump’s Executive Order 14154 means for your money (From Stansberry Research) (Ad) Buy CTOR Stock  Free CTOR Stock Alerts

Citius Oncology (CTOR) SEC Filings & 10K Form

Citius Oncology logo
$0.90 +0.03 (+3.66%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Citius Oncology SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
3:45 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:22 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K/A
01/07/2025
8:10 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/16/2024
4:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mayersohn Joel David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:08 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:08 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G/A
09/13/2024
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:23 AM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
WOLVERINE ASSET MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/30/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4/A
08/16/2024
4:25 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:34 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Citius Pharmaceuticals, Inc. (Filed by)
Form SC 13D
08/15/2024
11:53 AM		10XYZ Holdings LP (Filed by)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Form SC 13D/A
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:20 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:20 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:21 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:22 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:23 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:23 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:24 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:24 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:25 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:26 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:26 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:27 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:28 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:28 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Musk’s next move from the Oval Office? (Ad)

No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Trump himself said Musk was a "once-in-a-generation industry leader." The president has put him to work as an efficiency czar through the newly created DOGE.

Click here to find out about this latest executive order.
08/14/2024
5:29 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:33 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
08/09/2024
3:22 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
7:45 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
2:39 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
2:40 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
07/14/2024
11:15 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form EFFECT
07/12/2024
4:20 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 424B3
07/11/2024
2:50 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
07/11/2024
5:16 AM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
06/18/2024
12:35 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
12:36 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
06/17/2024
4:30 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
06/06/2024
4:28 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
4:29 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
05/21/2024
2:07 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
4:27 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:24 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form NT 10-Q
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CTOR) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
Trump announcement boosts “next Bitcoin”
President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...
Weiss Ratings | Sponsored
This Is How Empires Fall
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
Is he more powerful than Trump?
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Trump and Buffett Are Quietly Leading America’s Gold Revival
The “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...
Golden Portfolio | Sponsored
James Altucher: Do not invest in AI unless…
I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...
Paradigm Press | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
This isn’t a trade war. It’s worse…
Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...
Stansberry Research | Sponsored